Related Experiment Videos

Hypertension in a neonate with 11 beta-hydroxylase deficiency

Insights

This study reports on the youngest infant diagnosed with 11 beta-hydroxylase deficiency, presenting with hypertension at birth. Early diagnosis and hydrocortisone treatment normalized blood pressure in this rare congenital adrenal hyperplasia case.

Area of Science:

  • Endocrinology
  • Pediatrics
  • Genetics

Background:

  • Congenital adrenal hyperplasia (CAH) encompasses a group of genetic disorders affecting adrenal steroidogenesis.
  • 11 beta-hydroxylase deficiency is a rare form of CAH, leading to mineralocorticoid excess and hypertension.

Observation:

  • A female newborn presented with ambiguous genitalia and severe hypertension immediately after birth.
  • Elevated plasma levels of testosterone, delta 4-androstenedione, DHEA, and 17 OHP were noted.

Findings:

  • Diagnosis of 11 beta-hydroxylase deficiency was confirmed by elevated plasma eleven-deoxycortisol (compound S).
  • This is likely the youngest reported patient with 11 beta-hydroxylase deficiency presenting with neonatal hypertension.

Implications:

  • Highlights the importance of early screening for CAH in neonates with ambiguous genitalia and hypertension.
  • Successful management with hydrocortisone therapy underscores the efficacy of hormone replacement in normalizing blood pressure and steroid profiles.

Related Concept Videos